Glenmark Life Sciences: Nirma’s open supply and key insights on the inventory
Within the strategy of Nirma’s takeover of Glenmark Life Sciences (GLS) from its promoters Glenmark Pharma (GLP), an open supply to public shareholders can be constituted of February 15 to 29. With GLS buying and selling at ₹866 on February 13, owing to a turnaround in business state of affairs, the open supply value of … Read more